Concepedia

Striatal adenosine A2A receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats

Krystyna Gołembiowska, Anna Dziubina

Neuropharmacology · 2004 · 47 citations · 63 references

DOI

Concepts

References

63

Biochemical pathophysiology of Parkinson's disease.

O Hornykiewicz, Stephen J. Kish · PubMed · 1987 · 852 citations

, , +12

Tissue distribution of adenosine receptor mRNAs in the rat

Alistair K. Dixon, Amelie K. Gubitz, D.J.S. Sirinathsinghji et al. · British Journal of Pharmacology · 1996 · 564 citations · Full text

, , +7

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

Chong S. Lee, Ali Samii, Vesna Sossi et al. · Annals of Neurology · 2000 · 546 citations

, , +17

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text

, , +8

Adenosine A <sub>2A</sub> receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

, , +17